Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-01-28

FDA Approved: COLESEVELAM HYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

The FDA approved a supplemental application for Colesevelam hydrochloride by Glenmark Pharmaceuticals Inc., USA, resulting in approved changes under the supplem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Colesevelam hydrochloride (Colesevelam hydrochloride)

Snippet

SUPPL AP for COLESEVELAM HYDROCHLORIDE (COLESEVELAM HYDROCHLORIDE)